Skip to main content
  • Main menu
  • User menu
  • Search
  • English ▼
    • English
    • Afrikaans
    • Albanian
    • Amharic
    • Arabic
    • Armenian
    • Azerbaijani
    • Basque
    • Belarusian
    • Bengali
    • Bosnian
    • Bulgarian
    • Catalan
    • Cebuano
    • Chichewa
    • Chinese (Simplified)
    • Chinese (Traditional)
    • Corsican
    • Croatian
    • Czech
    • Danish
    • Dutch
    • Esperanto
    • Estonian
    • Filipino
    • Finnish
    • French
    • Frisian
    • Galician
    • Georgian
    • German
    • Greek
    • Gujarati
    • Haitian Creole
    • Hausa
    • Hawaiian
    • Hebrew
    • Hindi
    • Hmong
    • Hungarian
    • Icelandic
    • Igbo
    • Indonesian
    • Irish
    • Italian
    • Japanese
    • Javanese
    • Kannada
    • Kazakh
    • Khmer
    • Korean
    • Kurdish (Kurmanji)
    • Kyrgyz
    • Lao
    • Latin
    • Latvian
    • Lithuanian
    • Luxembourgish
    • Macedonian
    • Malagasy
    • Malay
    • Malayalam
    • Maltese
    • Maori
    • Marathi
    • Mongolian
    • Myanmar (Burmese)
    • Nepali
    • Norwegian
    • Pashto
    • Persian
    • Polish
    • Portuguese
    • Punjabi
    • Romanian
    • Russian
    • Samoan
    • Scottish Gaelic
    • Serbian
    • Sesotho
    • Shona
    • Sindhi
    • Sinhala
    • Slovak
    • Slovenian
    • Somali
    • Spanish
    • Sudanese
    • Swahili
    • Swedish
    • Tajik
    • Tamil
    • Telugu
    • Thai
    • Turkish
    • Ukrainian
    • Urdu
    • Uzbek
    • Vietnamese
    • Welsh
    • Xhosa
    • Yiddish
    • Yoruba
    • Zulu

Main menu

  • Home
  • Content
    • Current
      • JNMT Supplement
    • Ahead of print
    • Past Issues
    • Continuing Education
    • JNMT Podcast
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Rates
    • Journal Claims
    • Institutional and Non-member
  • Authors
    • Submit to JNMT
    • Information for Authors
    • Assignment of Copyright
    • AQARA Requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
    • Corporate & Special Sales
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNMT
    • JNM
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine Technology
  • SNMMI
    • JNMT
    • JNM
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine Technology

Advanced Search

English ▼
  • English
  • Afrikaans
  • Albanian
  • Amharic
  • Arabic
  • Armenian
  • Azerbaijani
  • Basque
  • Belarusian
  • Bengali
  • Bosnian
  • Bulgarian
  • Catalan
  • Cebuano
  • Chichewa
  • Chinese (Simplified)
  • Chinese (Traditional)
  • Corsican
  • Croatian
  • Czech
  • Danish
  • Dutch
  • Esperanto
  • Estonian
  • Filipino
  • Finnish
  • French
  • Frisian
  • Galician
  • Georgian
  • German
  • Greek
  • Gujarati
  • Haitian Creole
  • Hausa
  • Hawaiian
  • Hebrew
  • Hindi
  • Hmong
  • Hungarian
  • Icelandic
  • Igbo
  • Indonesian
  • Irish
  • Italian
  • Japanese
  • Javanese
  • Kannada
  • Kazakh
  • Khmer
  • Korean
  • Kurdish (Kurmanji)
  • Kyrgyz
  • Lao
  • Latin
  • Latvian
  • Lithuanian
  • Luxembourgish
  • Macedonian
  • Malagasy
  • Malay
  • Malayalam
  • Maltese
  • Maori
  • Marathi
  • Mongolian
  • Myanmar (Burmese)
  • Nepali
  • Norwegian
  • Pashto
  • Persian
  • Polish
  • Portuguese
  • Punjabi
  • Romanian
  • Russian
  • Samoan
  • Scottish Gaelic
  • Serbian
  • Sesotho
  • Shona
  • Sindhi
  • Sinhala
  • Slovak
  • Slovenian
  • Somali
  • Spanish
  • Sudanese
  • Swahili
  • Swedish
  • Tajik
  • Tamil
  • Telugu
  • Thai
  • Turkish
  • Ukrainian
  • Urdu
  • Uzbek
  • Vietnamese
  • Welsh
  • Xhosa
  • Yiddish
  • Yoruba
  • Zulu
  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • Continuing Education
    • JNMT Podcast
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Rates
    • Journal Claims
    • Institutional and Non-member
  • Authors
    • Submit to JNMT
    • Information for Authors
    • Assignment of Copyright
    • AQARA Requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
    • Corporate & Special Sales
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Watch or Listen to JNMT Podcast
  • Visit SNMMI on Facebook
  • Join SNMMI on LinkedIn
  • Follow SNMMI on Twitter
  • Subscribe to JNMT RSS feeds
Research ArticleCovid Commentaries

Post–COVID-19 New Normal for Molecular Imaging Departments: A United Kingdom Perspective

Jessica Williams, Emma Meadows and Manrita Singh
Journal of Nuclear Medicine Technology September 2020, 48 (3) 227-233; DOI: https://doi.org/10.2967/jnmt.120.252635
Jessica Williams
1Department of Molecular Imaging, HCA Healthcare UK, London, England; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Emma Meadows
1Department of Molecular Imaging, HCA Healthcare UK, London, England; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Manrita Singh
2Department of Molecular Imaging, University College London Hospital, London, England
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • FIGURE 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 1.

    Traffic light system guidance from the British Nuclear Medicine Society during COVID-19 pandemic. Green can be deferred, amber must be discussed with clinician before moving forward, and red is deemed essential and should not be cancelled or rescheduled (unless under extreme circumstances) (10).

  • FIGURE 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 2.

    Contingency plan for molecular imaging departments (11,20).

  • FIGURE 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 3.

    Recommended PPE for healthcare workers by secondary care inpatient clinical setting, NHS and independent sector. Footnotes: 1This may be single or reusable face/eye protection/full face visor or goggles. 2List of aerosol-generating procedures (AGPs) is included in section 8.1 at www.gov.uk/government/publications/wuhan-novel-coronavirus-infection-prevention-and-control/covid-19-personal-protective-equipment-ppe. (Note: AGPs are undergoing further review at present). 3Case is any individual meeting case definition for possible or confirmed case: https://www.gov.uk/government/publications/wuhan-novel-coronavirus-initial-investigation-of-possible-cases/investigation-and-initial-clinical-management-of-possible-cases-of-wuhan-novel-coronavirus-wn-cov-infection. 4Higher-risk acute areas include intensive care units/high-dependency units; emergency department resuscitation areas; wards with noninvasive ventilation; operating theatres; endoscopy units (for upper respiratory; ear, nose, and throat; or upper gastrointestinal endoscopy); and other clinical areas where AGPs are regularly performed. 5Single use refers to disposal of PPE or decontamination of reusable items (e.g., eye protection or respirator) after each patient or after completion of procedure, task, or session; dispose or decontaminate reusable items after each patient contact as per standard infection control precautions. 6Session refers to period during which health-care worker is undertaking duties in specific care setting/exposure environment (e.g., on ward round; providing ongoing care for inpatients). A session ends when health-care worker leaves care setting/exposure environment. Sessional use should always be risk-assessed and considered when there are high rates of hospital cases. PPE should be disposed of after each session or earlier if damaged, soiled, or uncomfortable. 7Risk-assessed use refers to using PPE when there is anticipated or likely risk of contamination with splashes, droplets of blood, or body fluids. 8For explanation of shielding and definition of extremely vulnerable groups, see guidance at https://www.gov.uk/government/publications/guidance-on-shielding-and-protecting-extremely-vulnerable-persons-from-covid-19/guidance-on-shielding-and-protecting-extremely-vulnerable-persons-from-covid-19. 9Ambulance staff conveying patients are not required to change or upgrade PPE for purposes of patient handover. Patient use of PPE: in cohort wards, communal waiting areas and during transportation, it is recommended that patients with suspected or confirmed cases wear surgical face mask if this can be tolerated. Aim is to minimize dispersal of respiratory secretions and to reduce both direct transmission risk and environmental contamination. Surgical face mask should not be worn by patients if there is potential for their clinical care to be compromised (e.g., when receiving oxygen therapy). (Reprinted from (19).)

  • FIGURE 4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 4.

    Recommended PPE for primary, outpatient, community, and social care by setting, NHS, and independent sector. Footnotes: 1This may be single or reusable face/eye protection/full face visor, or goggles. 2List of aerosol-generating procedures is included in section 8.1 at www.gov.uk/government/publications/wuhan-novel-coronavirus-infection-prevention-and-control/covid-19-personal-protective-equipment-ppe. (Note: aerosol-generating procedures are undergoing further review at present). 3Case is any individual meeting case definition for possible or confirmed case: https://www.gov.uk/government/publications/wuhan-novel-coronavirus-initial-investigation-of-possible-cases/investigation-and-initial-clinical-management-of-possible-cases-of-wuhan-novel-coronavirus-wn-cov-infection. 4Single use refers to disposal of PPE or decontamination of reusable items (e.g., eye protection or respirator) after each patient or after completion of procedure, task, or session; dispose or decontaminate reusable items after each patient contact as per standard infection control precautions. 5Single session refers to period when health-care worker is undertaking duties in specific care setting/exposure environment (e.g., on ward round) providing ongoing care for inpatients. Session ends when health-care worker leaves care setting/exposure environment. Sessional use should always be risk-assessed and considered when there are high rates of hospital cases. PPE should be disposed of after each session or earlier if damaged, soiled, or uncomfortable. 6Nonclinical staff should maintain 2-m social distancing, through marking out controlled distance; sessional use should always be risk-assessed and considered when there are high rates of community cases. 7Initial risk assessment should take place by phone before entering premises or at 2-m social distance on entering; when health or social care worker assesses that individual is symptomatic with suspected/confirmed cases, appropriate PPE should be put on before providing care. 8Risk-assessed use refers to using PPE when there is anticipated/likely risk of contamination with splashes, droplets or blood, or body fluids. 9For explanation of shielding and definition of extremely vulnerable groups, see guidance at https://www.gov.uk/government/publications/guidance-on-shielding-and-protecting-extremely-vulnerable-persons-from-covid-19/guidance-on-shielding-and-protecting-extremely-vulnerable-persons-from-covid-19. (Reprinted from (19).)

PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine Technology: 48 (3)
Journal of Nuclear Medicine Technology
Vol. 48, Issue 3
September 1, 2020
  • Table of Contents
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Email Article
Citation Tools
Share
Post–COVID-19 New Normal for Molecular Imaging Departments: A United Kingdom Perspective
Jessica Williams, Emma Meadows, Manrita Singh
Journal of Nuclear Medicine Technology Sep 2020, 48 (3) 227-233; DOI: 10.2967/jnmt.120.252635
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
Bookmark this article

Jump to section

  • Article
    • Abstract
    • ACUTE IMPACT ON PRACTICE
    • POST–COVID-19 PRACTICE
    • CONCLUSION
    • DISCLOSURE
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • A Virtual Success
  • Google Scholar

More in this TOC Section

  • Nuclear Medicine Clinical Practice in the United States During the COVID-19 Era and Beyond
  • Post–COVID-19 New Normal for Nuclear Medicine Practice: An Australasian Perspective
Show more Covid Commentaries

Similar Articles

  • Cardiac Sarcoidosis Imaging: PET
  • Patient Motion During Cardiac PET Imaging
  • PET Study Guide
  • Brain Imaging—PET: Amyloid
  • Brain Imaging—PET: Tau
See more

Keywords

  • molecular imaging
  • COVID-19
  • nuclear medicine
  • Pandemic
  • U.K
SNMMI

© 2025 SNMMI

Powered by HighWire
Alerts for this Article
Sign In to Email Alerts with your Email Address
Email this Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine Technology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Post–COVID-19 New Normal for Molecular Imaging Departments: A United Kingdom Perspective
(Your Name) has sent you a message from Journal of Nuclear Medicine Technology
(Your Name) thought you would like to see the Journal of Nuclear Medicine Technology web site.
Citation Tools
Post–COVID-19 New Normal for Molecular Imaging Departments: A United Kingdom Perspective
Jessica Williams, Emma Meadows, Manrita Singh
Journal of Nuclear Medicine Technology Sep 2020, 48 (3) 227-233; DOI: 10.2967/jnmt.120.252635

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

We use cookies on this site to enhance your user experience

By clicking any link on this page you are giving your consent for us to set cookies.